http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9118645-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_61f88efcda59d7062a4252ecf6886f58
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-0632
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-0618
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N5-06
filingDate 1991-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ac99a40419fb53162bdcbf468cf34410
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_60bff604001fc4c609ef4ebc89ce2181
publicationDate 1991-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-9118645-A1
titleOfInvention Treatment of immunodeficiency by visible light
abstract Exposure of human patients with an immunodeficiency to phototherapy resulted in an increase in the number and percentage of T-cells and other immune cells in these patients. The use in treating HIV and opportunistic infections and neoplasms is particularly noted. Beneficial results were noted after one week of treatment with very bright light.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2746321-A1
priorityDate 1990-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4858609-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406715
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408881
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21292785
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15764346
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID896
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406714
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127776308

Total number of triples: 22.